PlainPharmaWatch

CMS Open Payments · Program Year 2024

SCA Pharmaceuticals, LLC

SCA Pharmaceuticals, LLC reported $806.08 in payments to 7 physicians and teaching hospitals across 7 transactions.

$806.08
Total payments
7
Transactions
7
Recipients
−$5.5K
General Payments vs PY2023

SCA Pharmaceuticals, LLC reported $806.08 in payments to 7 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #1855 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $115.15 per recipient across 1 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

The verdict

SCA Pharmaceuticals, LLC pairs modest payment volume with a moderately concentrated payment pattern.

#1855
of 1,925 companies
0.0%
of all US industry payments
0.6%
paid to its single top recipient
1
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

SCA Pharmaceuticals, LLC's CMS-reported General Payments decreased by $5.5K (−87.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: SCA PHARMACEUTICALS, LLCPY2023: SCA PHARMACEUTICALS, LLCPY2024: SCA Pharmaceuticals, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$6.3KPY2024$806.08
PY2023
$6,279.33
PY2024
$806.08

How SCA Pharmaceuticals, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

SCA Pharmaceuticals, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$806 4th percentile higher than 4% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). This entry sits in this band. $838–$2,603: 76 reporting companies (4%). Above this entry. $2,603–$8,084: 114 reporting companies (6%). Above this entry. $8,084–$25,112: 167 reporting companies (9%). Above this entry. $25,112–$78,003: 249 reporting companies (13%). Above this entry. $78,003–$242,294: 295 reporting companies (15%). Above this entry. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for SCA Pharmaceuticals, LLC

Averaging $115.15 per transaction and $115.15 per recipient, SCA Pharmaceuticals, LLC's Program Year 2024 total comes to $806.08 across 7 transactions and 7 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1855 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $806.08 (100.0% of the company's reported total, 7 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

"Food and Beverage" leads SCA Pharmaceuticals, LLC's 1-category general-payment breakdown at $806.08, 100.0% of the reported total.

How SCA Pharmaceuticals, LLC divides its payments

How the reported total splits across payment categories

1. Food and Beverage$806.08
Payment Type Amount Transactions
Food and Beverage $806.08 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $806.08 (100.0%) of $806.08 in this company's General Payments records across 5 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for SCA Pharmaceuticals, LLC

The five named recipients with the highest reported General Payments from this company

Nyu Langone Hospitals$466.71Ronald Reagan UCLA$128.76Montefiore Medical Center$83.60Westchester Medical Center$83.60Umass Memorial Medical Center$43.41
  1. 1

    Nyu Langone Hospitals

    $466.71 across 3 reported transactions

  2. 2

    Ronald Reagan UCLA

    $128.76 across 1 reported transactions

  3. 3

    Montefiore Medical Center

    $83.60 across 1 reported transactions

  4. 4

    Westchester Medical Center

    $83.60 across 1 reported transactions

  5. 5

    Umass Memorial Medical Center

    $43.41 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $115.15. Average per recipient: $115.15.

Total Amount

$806.08

Avg per Transaction

$115.15

Avg per Recipient

$115.15

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

SCA Pharmaceuticals, LLC Share

0.0%

#1855 by total payments

Frequently Asked Questions

How much did SCA Pharmaceuticals, LLC pay to physicians and hospitals in 2024?
SCA Pharmaceuticals, LLC made $806.08 in payments to physicians and hospitals in Program Year 2024, across 7 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from SCA Pharmaceuticals, LLC?
Averaging $115.15 per recipient, SCA Pharmaceuticals, LLC's 2024 payments reached 7 physicians and teaching hospitals.
What types of payments did SCA Pharmaceuticals, LLC make?
SCA Pharmaceuticals, LLC made 1 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Food and Beverage" at $806.08, representing 100.0% of the company's reported total.
How does SCA Pharmaceuticals, LLC rank among pharmaceutical companies?
SCA Pharmaceuticals, LLC ranks #1855 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from SCA Pharmaceuticals, LLC?
In 2024, SCA Pharmaceuticals, LLC averaged $115.15 per transaction across 7 transactions to 7 recipients.
Where does the payment data for SCA Pharmaceuticals, LLC come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download SCA Pharmaceuticals, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.